Glucagon-Like Peptide 1 Receptor Agonists and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients With Type 2 Diabetes
GLP-1 RAs were associated with an increased 1-year risk of NAION compared with DPP-4 inhibitors among adults with type 2 diabetes, particularly in younger patients, men, ever-smokers, and patients with a marked hemoglobin A1c reduction.
Authors
- Yunha Noh (ORCID: https://orcid.org/0000-0002-3645-7358)
- I. Ben Ghezala
- Samy Suissa
- Laurent Azoulay
- Oriana H.Y. Yu
- Hui Yin
Institutions
- Chonnam National University (KR)
- Inserm (FR)
- McGill University Health Centre (CA)
- Jewish General Hospital (CA)
- Maison des Sciences sociales et des Humanités de Dijon (FR)
- McGill University (CA)
Publication Details
- Journal
- Diabetes Care
- Published
- 2026-02-17
- DOI
- https://doi.org/10.2337/dc25-2577
- Primary Topic
- Intraoperative Neuromonitoring and Anesthetic Effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00